Patent ID: 7977369
Filing Date: 2011-07-12
Classification: A61K,A61P,Y10S

Abstract:
1. A method for treating bladder cancer comprising administering via intravesical administration to the bladder a stabilized pharmaceutical formulation comprising a therapeutically effective dose of 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methyl-1H-indole-4,7-dione (EO9) and an adhesive agent selected from the group consisting of propylene glycol, hydroxypropylcellulose, carboxymethylcellulose, chitosan hydrochloride, lectin, and polycarbophil; wherein said stabilized pharmaceutical formulation is instilled into the bladder for a time sufficient to treat the bladder cancer.